Partner

Articles & Insights / Nutraceutical Development

Developing Stable Vitamin and Mineral Combinations

Combining nutrients creates a formulation system with its own chemistry. Ingredient selection, moisture control, physical separation and analytical coverage determine whether the intended combination remains usable throughout its shelf life.

Stabicon Life Sciences3 min read

Accreditations, approvals & registrations

  • Prequalified by WHO, Geneva

    One of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

  • Accredited by ISO/IEC 17025:2017 (NABL)

  • Approved by FSSAI

  • Approved by CDSCO, India

  • Facility Registered with FDA, Karnataka

  • Registered with DSIR

  • Registered with AYUSH

All articles

What this article helps you consider

  • Build a realistic product brief
  • Investigate the combination rather than isolated ingredients
  • Select forms and separation strategies

Build a realistic product brief

Define the target population, permitted nutrient forms, daily serving, dosage format and intended market before selecting the composition. Assess nutritional purpose and safety alongside formulation feasibility. A long ingredient list can create a tablet too large to use comfortably or a powder with unacceptable taste and flow.

Calculate the mass of each ingredient required to deliver the declared nutrient quantity. A mineral salt contains only a fraction of its mass as elemental mineral. Carriers and encapsulating materials increase the required ingredient mass further. This calculation often determines whether one tablet, multiple units or a powder serving is realistic.

Investigate the combination rather than isolated ingredients

A vitamin stable on its own may behave differently in a mixture. Moisture can increase molecular mobility and facilitate reactions. Transition-metal species can promote oxidation in susceptible systems. Changes in local pH, light exposure or contact with other ingredients can influence the outcome. These are hypotheses to examine in the actual formulation, not universal incompatibility rules.

Published work on vitamin powder blends has shown that moisture-related behaviour, including deliquescence, can affect chemical stability. The practical implication is to investigate the blend under relevant conditions rather than extrapolate directly from the stability of its components. R26

Select forms and separation strategies

Compare nutrient forms on potency, solubility, taste, stability and regulatory acceptability. A coated or encapsulated ingredient may reduce contact with reactive components, but the coating must survive processing and release appropriately during use. Compression, mixing and handling can damage protection if they are not considered during development.

Physical separation may be achieved through granules, layered structures or separate units. The illustration shows a conceptual comparison between direct contact and separated particles. It makes no claim that one design will improve every formulation. Additional materials and processing can create their own stability, uniformity and cost implications.

Explore the scienceNutraceutical Development

Contact and particle protection

Direct contactCoated particles

Protection is a hypothesis to evaluate. Confirm processing survival, uniformity and appropriate release for the actual formulation.

Ingredient contact

The combined matrix can behave differently from isolated ingredients.

Conceptual illustration. Select a topic to explore its role. The visual does not establish formulation performance or prescribe universal regulatory requirements.

Conceptual ingredient contact and coated-particle separation. Barrier effectiveness, processing survival, uniformity and appropriate release require formulation-specific evidence.

Control moisture at several stages

Characterise the moisture behaviour of the blend, including relevant interactions among hygroscopic components. Water content and water activity describe different aspects of the system and should not be treated as interchangeable. Select the measurement that answers the stability or microbial question under investigation.

Assess environmental exposure during dispensing, mixing, compression and packing. A strong barrier pack cannot reverse damage already initiated by prolonged process exposure. Define hold times and environmental controls where evidence shows they matter. Desiccants and moisture-barrier packaging should be confirmed with the final product and fill configuration.

Design the analytical programme for multiple nutrients

One marker cannot establish the stability of every ingredient in a multicomponent product. Select methods capable of extracting and measuring nutrients in the combined matrix. Minerals may require a different analytical preparation from vitamins, while low-dose components need sufficient sensitivity and control of sample homogeneity.

A hypothetical calcium, vitamin D and vitamin K combination illustrates the issue. The mineral may remain chemically measurable while one low-dose vitamin declines. A total tablet-weight check would reveal neither the nutrient loss nor unit-to-unit distribution. The quality programme must reflect the properties and dose of the individual constituents.

Justify any overage

An overage is an added quantity above the declared amount intended to compensate for a justified loss or variability. Its use must remain within the applicable regulatory and safety framework. It should not substitute for solving a preventable instability or make initial exposure exceed permitted limits.

For illustration, if a permitted formulation process reproducibly retains 95% of an ingredient, dividing the target by 0.95 estimates the input needed to offset that particular loss. This simplified calculation excludes assay variability, storage loss, safety margins and regulatory limits. Establish any actual overage using product-specific evidence and document the basis separately for each nutrient.

Advance candidates using representative batches, intended packaging and a justified shelf-life programme. Evaluate sensory acceptability alongside chemistry because changes in flavour, odour or texture can make a technically compliant product unusable. Stabicon can bring formulation, analytical and stability work together to develop combinations whose performance is supported across the intended product life.

References & further reading

Read the source in its stated scope. Requirements, amendments and compendial editions depend on the product and target market. Draft guidance is identified separately.

  1. R14
    FSSAI Food Safety Management Systems Guidance for Food Supplements

    Guidance document, 2018. Practical food-supplement manufacturing and hygiene context; not a replacement for current regulations.

  2. R21
    FSSAI Health Supplements and Nutraceuticals Standards

    Official regulations portal. Verify current amendments, permitted ingredients, levels and category-specific requirements.

  3. R26
    Impact of Deliquescence on the Chemical Stability of Vitamins B1 B6 and C in Powder Blends

    Primary research, 2008. PubMed PMID 18593179. Specific experimental matrices; no universal threshold inferred.

From insight to a defined programme

Bring your next technical question.

Share your formulation, testing objective or development challenge. Stabicon can review the context and define a suitable scope of work.

Discuss this topic with Stabicon

Continue reading

Related scientific perspectives.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Request a consent withdrawal at bd@stabicon.com.

Press Kit

Logos, company information & spokesperson details – available from our media team.

Request Press Kit

Accreditations

Prequalified by WHO, GenevaAccredited by ISO/IEC 17025:2017 (NABL)Approved by FSSAIApproved by CDSCO, IndiaFacility Registered with FDA, KarnatakaRegistered with DSIRRegistered with AYUSHOne of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin